After an incredible performance in late March, when shares of Acadia Pharmaceuticals (ACAD 2.56%) jumped up 23%, they have once again exploded today, up 40% intraday. What's behind these massive leaps for this pharmaceutical company, and is there more on the way? In this video, Motley Fool health-care analyst David Williamson tells investors about the drug that has Acadia investors so excited, why it has so many competitive advantages, and what investors need to watch from here.
Acadia Leaps Toward the Finish Line
By Dave Williamson
-
Apr 11, 2013 at 6:22PM
You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More
NASDAQ: ACAD
Acadia Pharmaceuticals
Market Cap
$3B
Today's Change
(2.56%) $0.42
Current Price
$17.02
Price as of May 17, 2022, 4:21 p.m. ET
Shares of Acadia Pharmaceuticals exploded today. What's behind this stock price skyrocket?
Stocks Mentioned
Acadia Pharmaceuticals
ACAD
$17.02
(2.56%)
$0.42
Pfizer Inc.
PFE
$51.34
(1.31%)
$0.67
Bristol Myers Squibb Company
BMY
$78.08
(1.51%)
$1.17
Eli Lilly and Company
LLY
$300.53
(0.38%)
$1.15
*Average returns of all recommendations since inception. Cost basis and return based on previous market day close.
Related Articles
Why Acadia Pharmaceuticals Stock Climbed More Than 10% Wednesday
Why Acadia Pharmaceuticals Stock Is Rocketing Today
Why Acadia Pharmaceuticals Stock Is Crashing Today
What's Behind Acadia Pharmaceuticals' Mixed Q3 Results
2 Biotech Stocks With Major Incoming Catalysts
Motley Fool Returns
Market-beating stocks from our award-winning service.
Stock Advisor Returns
338%
338%
S&P 500 Returns
119%
Calculated by average return of all stock recommendations since inception of the Stock Advisor service in February of 2002. Returns as of 05/17/2022.
Discounted offers are only available to new members. Stock Advisor list price is $199 per year.
Cumulative Growth of a $10,000 Investment in Stock Advisor
Calculated by Time-Weighted Return since 2002. Volatility profiles based on trailing-three-year calculations of the standard deviation of service investment returns.
Premium Investing Services
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.